Magnetic Ventures
Venture capitalActively deployingBoston · Seed–Series A · 9 people tracked
Also known as Magnetic Ventures AVR
Find your way into Magnetic Ventures
2,808 people in our graph share verified history with the Magnetic Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Magnetic Ventures invests in visionary founders using deep technology to revolutionize the life sciences. Founded in 2018 on the thesis that technology will transform every aspect of life sciences, the firm leads early-stage investments across the life science ecosystem. It backs companies from seed through later stages of their life cycle, offering hands-on support during formative company-building phases. Leveraging early access to emerging technology and startup deal flow, the firm aims to identify breakthrough opportunities at the earliest stages and provide founders with resources beyond capital to accelerate growth and maximize impact.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from the firm's website & public directories)
)
)
)
What they invest in
from 19 of 25 portfolio companiesBiotech ×12AI & Machine Learning ×10Healthtech ×8Deep Tech ×6Digital Health ×6Medical Devices ×4Impact & Social Good ×2SaaS ×2
HQs:United States×15Canada×1
Who they back
founder profiles across 11 portfolio companiesFounding team size:solo founder×52 founders×33 founders×24+ founders×1
Where their founders studiedfrom 14 founders with education data
Columbia University ×2Stanford University School of Medicine ×2
What their founders studiedfrom 13 founders with field-of-study data
Life Sciences ×6Business & Management ×2Chemistry ×2Computer Science ×2Engineering ×2
Where their founders worked beforefrom 15 founders with career history
Columbia University in the City of New York ×2Gilgamesh Pharma ×2McKinsey & Company ×2Roivant Sciences ×2
Investments · 25 tracked
founders shown can be your intro pathBy year:2026 · 32025 · 12023 · 22022 · 22021 · 12020 · 211 dated
Amydis develops proprietary ocular tracers that detect molecular biomarkers for diseases of the eye, heart, and brain through non-invasive eye-based testing.
BiotechDigital HealthMedical DevicesLos Angeles, US
Stella Sarraf(Executive Officer, Director)inJames Khodabakhsh(Director)Mervyn Turner(Director)Faith Charles(Director)
Board seatChristine Aylward· per SEC Form D · $6M raise · filed Dec 2023
AppliedVR develops immersive therapeutic software using technology to deliver drug-free clinical treatments for patients.
Digital HealthHealthtechMedical DevicesLos Angeles, US
Matthew Stoudt(Co-Founder and CEO)inJosh Sackman(Co-Founder and President)in
BoardDavid Sackman(Chairman)
Co-investorsEntrada VenturesF-Prime CapitalJAZZ Venture PartnersPresence CapitalTechstars
Deep Genomics develops AI-based biological foundation models to identify drug targets and design molecules, aiming to speed up drug discovery.
AI & Machine LearningBiotechDeep TechToronto, CA
Brendan Frey(Chief Innovation Officer and Founder)inBrian O'Callaghan(Chief Executive Officer)inDavid Johnston(Chief Financial Officer)inClive Bertram(Chief Business Officer)inTom Masterson(Chief Operating Officer)inGreg Hoffman(Chief Scientific Officer)in
Co-investors11.2 CapitalFuture VenturesKensington Capital Partners LimitedSoftBank Vision FundTrue VenturesBloomberg Beta
Eclipsebio provides RNA biology analytical services and sequencing-based assays that help drug developers and researchers characterize RNA at nucleotide-level resolution and generate datasets for AI-driven drug discovery.
AI & Machine LearningBiotechDeep TechSan Diego, US
Eugene Yeo(Director)Peter Chu(Executive Officer, Director)inEric L Van Nostrand(Director)Hallie Kuhn(Director)
BoardEdmond Wong(Director)inDaniel Vasella(Director)
Co-investorsBrainstorm VenturesiGlobe PartnersPhoenix Venture Partners
Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.
AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US
Jonathan Sporn(Founder)inAndrew Kruegel(Founder)inDalibor Sames(Founder)inJONATHAN SPORN(Founder)inAndrew Kruegel, Ph.D.(Executive Officer)Jonathan Sporn, M.D.(President and Chief Executive Officer)in
Co-investorsAera VCFrontera Technology VenturesFrontier Path VCJames Beshara FundJLSNoetic+9 more
GroundGame.Health operates a technology platform and hyperlocal operating model that connects health plans, providers, employers, and community-based organizations to address barriers to care and social determinants of health.
Digital HealthHealthtechImpact & Social GoodSocialTampa, US
Susan Rawlings Molina(Executive Officer, Director, Promoter)inSridhar Akula(Executive Officer, Director)Aimee Dailey(Director)
BoardRobert Garber(Director)inShantanu Agrawal(Director)Jennifer Jarrell(Director)
Co-investors7wire VenturesCorewell Health VenturesRaptor Group
HiberCell develops therapeutic candidates targeting the Integrated Stress Response pathway to address treatment-resistant cancers, relapse, and metastasis.
BiotechMedical Devices
Julio Aguirre-Ghiso, Ph.D.(Co-Founder)
Co-investorsARCH Venture PartnersRaptor GroupHercules Capital, Inc.
Paradigm Health operates a platform that increases patient access to clinical trials through a provider-facing infrastructure combined with AI-powered research technology.
AI & Machine LearningHealthtechMedical DevicesSaaSColumbus, US
Kent Thoelke(Founder and Chief Executive Officer)inJonathan Hirsch(Chief Strategy and Growth Officer)
Co-investorsARCH Venture PartnersGeneral CatalystLux CapitalF-Prime CapitalGV (Google Ventures)Mubadala Capital
.png)
Prompt is an Ambient AI product and research company that develops human-centered AI products designed to sense the physical environment.
AI & Machine LearningConsumerDeep TechSan Francisco, US
Tete Xiao(Founder)in
Co-investorsAbstract VenturesAIX VenturesDCVC (Data Collective)Neotribe VenturesBraidwellCDP Venture Capital+3 more
Proxima is a biotech company developing proximity therapeutics through a drug discovery engine and a structural proteomics data platform.
AI & Machine LearningBiotechDeep Tech
Jonathan Bernardini(Founder)inZachary Carpenter(Co-founder & CEO)inLuca Naef(Co-founder & CTO)in
Co-investorsModi VenturesDCVC (Data Collective)
Proxima develops AI-powered gaming experiences and infrastructure, with a focus on embodied AI agents and applied AI systems for interactive entertainment.
AI & Machine LearningGamingSan Francisco, US
Ran Mo(Founder)in
Co-investorsKonvoy VenturesProgressionAIX VenturesAlexandriaBalderton CapitalBayern Kapital+9 more
Relation RX is a biotech company focused on discovering novel medicines through an interdisciplinary approach combining expertise from technology, pharma, academia, and venture.
AI & Machine LearningBiotechDeep Tech
David Roblin(Chief Executive Officer)in
Co-investorsDCVC (Data Collective)Hitachi VenturesRaptor GroupNVentures
Resilience is a contract development and manufacturing organization (CDMO) that manufactures complex pharmaceutical products and active pharmaceutical ingredients to broaden access to medicines and protect biopharmaceutical supply chains against disruption.
Advanced ManufacturingBiotechEnterprise SoftwareBlue Ash, US
William S. Marth(Chief Executive Officer)
BoardRobert Nelsen
Co-investors8VCARCH Venture PartnersCatalio Capital Management, LPGV (Google Ventures)Koch Disruptive TechnologiesLux Capital+5 more
Digital HealthHealthtechImpact & Social Good
Co-investors7wire VenturesCorewell Health VenturesRaptor Group
HealthtechSan Francisco, US
ALEXANDER MARSON(Executive Officer, Director)PATRICK DAVID HSU(Director)JACOB CORN(Director)
BoardBLAKE BYERS(Director)in
Co-investorsGV (Google Ventures)
Stipple Bio develops targeted oncology therapies that act on tumor-specific cell surface epitopes to expand druggable targets and improve therapeutic index for cancer patients.
BiotechHealthtechCambridge, US
Aaron Ring(Co-founder)inAashish Manglik(Co-founder)inJeff Landau(Chief Executive Officer)inRoland Gendron(Chief Business Officer)inMichelle Zhang(Chief Scientific Officer)in
BoardVineeta Agarwala(Director)in
Co-investorsRA CapitalAndreessen HorowitzOMX VenturesAxial VCGV (Google Ventures)LoLa Capital Partners+1 more
Transition Bio applies methods from physics, chemistry, biology, and machine learning to study protein biophysics—including protein aggregation, self-assembly, and protein-protein interactions—for developing therapeutics targeting health and disease.
AI & Machine LearningBiotechDeep TechCambridge, US
Tuomas Knowles(Executive Director, Co-Founder & Chief Technology Officer)Samuel Cohen(Executive Director & Co-Founder)inG. Kelly Martin(Executive Chairman & Co-Founder)George Martin(Executive Officer, Director)inStephanie Torruella(Executive Officer)inPreet Makkar(Executive Officer)
Co-investorsNorthpond VenturesLifeforce CapitalTaiho Ventures, LLCDolby Family Ventures
Triveni Bio develops genetics-informed antibody therapeutics aimed at treating complex immunology and inflammation (I&I) diseases.
BiotechDigital HealthHealthtech
Co-investorsAtlas VentureBorealis VenturesBorealis VenturesOrbiMedAscenta CapitalFidelity Investments+3 more
Weave Bio offers an AI-native regulatory platform for preparing and managing eCTD-formatted regulatory dossiers, automating data organization, authoring, review, publishing and response management across the therapeutic lifecycle.
AI & Machine LearningBiotechSaaSSan Francisco, US
Ari Caroline(Co-founder, Chief Strategy Officer)inBrandon Rice(Co-founder, Chief Executive Officer)in
Co-investorsFirsthandVCGround Up VenturesRaptor GroupTMVUS Venture PartnersCharacter+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Relation TherapeuticsWeave Platform, Inc.EmmeGilgameshRelationSameSky Health
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
1 acquisitionsSameskyacq. by GroundGame.Health
Portfolio news
latest coverage across their companies
Triveni · fiercebiotech.com · Aug 12, 2026
Resilience · tectonicdefense.com · Jul 17, 2026
Gilgamesh Pharmaceuticals · wmbdradio.com · Jul 16, 2026
Proxima · finance.yahoo.com · Jul 7, 2026
Proxima · finance.yahoo.com · Jul 7, 2026
Proxima · finance.yahoo.com · Jul 7, 2026
Stipple Bio · bioxconomy.com · Apr 10, 2026
Paradigm Health · bizjournals.com · Dec 16, 2025
Frequently asked questions
- How many investments has Magnetic Ventures made?
- Magnetic Ventures has 25 tracked investments, 1 of which have exited, including 4 dated in the last 24 months.
- What stage does Magnetic Ventures invest at?
- Magnetic Ventures invests at the Seed, Series A stages.
- What is Magnetic Ventures's typical check size?
- Magnetic Ventures typically writes checks of $1M – $6M.
- What sectors does Magnetic Ventures focus on?
- Magnetic Ventures focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Magnetic Ventures located?
- Magnetic Ventures is headquartered in Boston, US.
- Does Magnetic Ventures lead rounds?
- Yes, Magnetic Ventures leads investment rounds.
- Who does Magnetic Ventures co-invest with?
- Magnetic Ventures most often shares deals with Raptor Group, ARCH Venture Partners, 7wire Ventures, among 51 tracked co-investors.
Co-investors · 11
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Innovation Endeavors is an early-stage venture fund that invests in founders and supports venture creation through pre-team and pre-idea programs. The firm provides portfolio companies with access to mentors, advisors, and an entrepreneur ecosystem.
CRV is a venture capital firm that backs founders at the seed and Series A stages, focusing on those with deep conviction and unique insights.
Inovia Capital is a full-stack venture capital firm based in Canada with a presence in the EU, partnering with founders to build global technology companies.
Practical Venture Capital (PVC) is a venture firm focused on the secondary market for private, late-stage technology companies. It acquires stakes in mature companies through its Halftime Fund.
LOI Venture is a seed-stage venture fund co-founded by Hootsuite Founder Ryan Holmes and Angel Investor Manny Padda focused on backing founders under 30 usually building tech products attending the LOI Program.
Golden Ventures is a seed-stage venture capital firm that backs early-stage technology companies, with a portfolio concentrated in Canada.
Structure Capital is a seed-stage venture capital firm that provides funding and support to early-stage companies. The firm offers capital, mentorship, and network access to portfolio companies.
Highline Beta is a venture studio and venture capital firm that co-creates new ventures with corporate partners and co-invests alongside founders. It helps enterprises design, launch, and run corporate venture studios and build new ventures from idea to launch.
Deeptech Labs is an accelerator and venture capital fund based in Cambridge that invests in deep technology companies. The firm leverages resources from Cambridge's academic and commercial sectors.
Concrete Ventures is an early-stage venture capital firm focused on backing founders and startups in Atlantic Canada that aim to build highly scalable businesses.
Firms observed investing alongside Magnetic Ventures, from public investor directories. Shared companies are the overlap with Magnetic Ventures's recorded portfolio.
Similar investors
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.